Establishes an emergency insulin program

This bill creates a state-run emergency insulin program to provide immediate access to analog insulin supplies for uninsured or underinsured people with type 1 or insulin-dependent type 2 diabetes who face serious health risks due to insulin shortages. It allows healthcare professionals and pharmacists to dispense insulin without a prescription during emergencies, requires large pharmacies to register as program participants by 2026, and caps costs at $100 for a 30-day supply. Funding comes from a new trust fund supported by manufacturer contributions and state appropriations, with the program required to be operational by April 2026. The program mandates annual reporting on participants, insulin types provided, costs, and public-private partnerships to the governor and health committees.